Skip to main content
. 2023 May 18;15(5):1188. doi: 10.3390/v15051188

Table 4.

Possible Drugs and their corresponding details.

Human Genes Drugs Adjusted p-Value Drug Bank ID Treatment
ARF1, PPP2R1A, HNRNPH1, P4HB, ACTB Nitrofural 0.0052 DB00336 Topical antibacterial for the prevention and treatment of bacterial infections of the skin
SEC61A1, ARF1, DNAJC7, PCBP1, PSMD2, TECR, CYC1, P4HB, ACTB, PFKP Clindamycin 0.0077 DB01190 Antibiotic used to treat serious infections caused by susceptible anaerobic, streptococcal, staphylococcal and pneumococcal bacteria
HNRNPH1, PSMD2, NCL, ACTB, ARCN1 Ipratropium Bromide 0.0101 DB00332 Used in the control of symptoms related to bronchospasm in chronic obstructive pulmonary disease (COPD)
ARF1, PRPF6, PPP2R1A, TECR, RPLP2, ACTB Ambroxol 0.0130 DB06742 Airway secretion clearance therapy
ARF1, PPP2R1A, TECR, P4HB, ACTB Paclitaxel 0.0133 DB01229 Treatment of advanced carcinoma of the ovary, and other various cancers including breast and lung cancer
ARF1, PPP2R1A, ACTB Benserazide 0.0236 DB12783 Treat Parkinson’s disease, Parkinsonism, and restless leg syndrome
ARF1, PPP2R1A, HNRNPH1, ACTB Amikacin 0.0351 DB00479 An aminoglycoside used to treat infections caused by more resistant strains of Gram-negative bacteria and some Gram-positive bacteria
ARF1, P4HB, ACTB Captopril 0.0420 DB01197 An ACE inhibitor used for the management of essential or renovascular hypertension, congestive heart failure, left ventricular dysfunction following myocardial infarction and nephropathy